Dr. Chen is the founder of APT Therapeutics™ and the inventor of APT's key technologies. He has been CSO since APT's incorporation. Dr. Chen was instrumental in defining the business vision, assembling a top-tier technical team and raising Series A capital for the company. Dr. Chen previously built and led the protein engineering team at Monsanto/Pharmacia for nutraceutical development. Dr. Chen also held a research position of human antibody engineering at Genentech. Prior to working for the biotech industry, Dr. Chen was a tenure-track faculty of Biochemistry at the University of Saskatchewan Medical School. During his tenure, he established extramurally funded programs in enzymology and protein engineering. Dr. Chen has published over 40 scientific peer-reviewed research articles, four book chapters and five patents and patent applications. Dr. Chen holds a Ph.D. in Biochemistry from University of Paris.